Literature DB >> 24850225

Validity of Oxygen Uptake Efficiency Slope in patients with multiple sclerosis.

Martin Heine1, Olaf Verschuren, Gert Kwakkel.   

Abstract

OBJECTIVE: To examine the Oxygen Uptake Efficiency Slope (OUES) as an outcome for physical fitness in patients with multiple sclerosis.
DESIGN: Cross-sectional study. PATIENTS: A maximal cycling ergometry test was performed by 56 patients with multiple sclerosis.
METHODS: The OUES was compared with healthy reference values. Correlation analysis was used to assess the concurrent validity of the OUES and the following commonly used parameters of maximal exercise testing: maximal power output (Wmax) and peak oxygen consumption (VO2peak). The predictive validity of a submaximal OUES, derived using only 50% of the exercise duration (OUES50), and an OUES derived using the full exercise duration (OUES) were determined.
RESULTS: The OUES (mean 24.2 (standard deviation; SD 7.2)) was markedly lower than previously reported healthy reference values (mean 46.0 (SD 9.0)). Pearson correlation coefficients ranged from 0.514 (p < 0.01) between the OUES and Wmax and 0.857 for VO2peak (p < 0.01). The predictive validity of OUES50 for OUES was 0.918 (p < 0.01).
CONCLUSION: The moderate to high concurrent validity of the OUES with Wmax and VO2peak and high predictive validity of OUES50 for OUES suggest that maximal exercise testing in patients with low to moderate multiple sclerosis is not necessary.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24850225     DOI: 10.2340/16501977-1825

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  8 in total

1.  Reliability and responsiveness of cardiopulmonary exercise testing in fatigued persons with multiple sclerosis and low to mild disability.

Authors:  Martin Heine; Lizanne Eva van den Akker; Olaf Verschuren; Anne Visser-Meily; Gert Kwakkel
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

Review 2.  Aerobic capacity in persons with multiple sclerosis: a systematic review and meta-analysis.

Authors:  Martin Langeskov-Christensen; Martin Heine; Gert Kwakkel; Ulrik Dalgas
Journal:  Sports Med       Date:  2015-06       Impact factor: 11.136

3.  Reliability and minimal detectable change of a new treadmill-based progressive workload incremental test to measure cardiorespiratory fitness in manual wheelchair users.

Authors:  Cindy Gauthier; Jasmine Arel; Rachel Brosseau; Audrey L Hicks; Dany H Gagnon
Journal:  J Spinal Cord Med       Date:  2017-09-13       Impact factor: 1.985

4.  Comprehensive Profile of Cardiopulmonary Exercise Testing in Ambulatory Persons with Multiple Sclerosis.

Authors:  Rachel E Klaren; Brian M Sandroff; Bo Fernhall; Robert W Motl
Journal:  Sports Med       Date:  2016-09       Impact factor: 11.136

5.  Oxygen uptake efficiency slope as a useful measure of cardiorespiratory fitness in morbidly obese women.

Authors:  Tatiana Onofre; Nicole Oliver; Renata Carlos; Amanda Felismino; Renata Cristina Corte; Eliane Silva; Selma Bruno
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

6.  The validation of oxygen uptake efficiency slope in patients with stroke.

Authors:  Sheng-Chieh Han; Tieh-Cheng Fu; Chih-Chin Hsu; Shu-Chun Huang; Hsin-Yu Lin; Jong-Shyan Wang
Journal:  Medicine (Baltimore)       Date:  2021-10-22       Impact factor: 1.817

7.  Ventilatory efficiency and aerobic capacity in people with multiple sclerosis: A randomized study.

Authors:  Stine Maren Riksfjord; Siri Merete Brændvik; Ola D Røksund; Inger-Lise Aamot
Journal:  SAGE Open Med       Date:  2017-12-12

8.  Vigorous cool room treadmill training to improve walking ability in people with multiple sclerosis who use ambulatory assistive devices: a feasibility study.

Authors:  Augustine J Devasahayam; Arthur R Chaves; Wendy O Lasisi; Marie E Curtis; Katie P Wadden; Liam P Kelly; Ryan Pretty; Alice Chen; Elizabeth M Wallack; Caitlin J Newell; John B Williams; Hannah Kenny; Matthew B Downer; Jason McCarthy; Craig S Moore; Michelle Ploughman
Journal:  BMC Neurol       Date:  2020-01-22       Impact factor: 2.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.